96 results
Page 3 of 5
8-K
0bgw4
20 Jan 21
Departure of Directors or Certain Officers
8:01am
8-K
EX-3.3
c9s3vzam
20 Jan 21
Departure of Directors or Certain Officers
8:01am
8-K
EX-10.1
7plh gdjij
20 Jan 21
Departure of Directors or Certain Officers
8:01am
424B5
q4is9 s0v
23 Dec 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-10.1
szwkee5t t8c
9 Dec 20
Other Events
9:03am
PRER14A
rhwl1 zqj5asajj
8 Dec 20
Preliminary revised proxy
4:11pm
S-8
EX-99.1
ng7n x4i8i80
24 Nov 20
Registration of securities for employees
8:26am
8-K
EX-2.1
iee4ee5q7xpqb
28 Oct 20
Acquisition includes clinical stage anti-IGF-1R monoclonal antibody, VRDN-001, intended for Company plans to use private placement financing proceeds of $91 million to advance multiple
9:28am
8-K
jux97o rv65
17 Sep 20
Lee Rauch appointed President and CEO, following resignation by William Marshall
5:24pm
8-K
EX-10.2
820om bdn20
17 Sep 20
Lee Rauch appointed President and CEO, following resignation by William Marshall
5:24pm
8-K
EX-10.3
3rl 48juae9jvliddutq
17 Sep 20
Lee Rauch appointed President and CEO, following resignation by William Marshall
5:24pm